Alpha 2.0
Login Register
» Articles » PMID: 28409739

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016

Overview
Journal Emerg Infect Dis
Specialty Infectious Diseases
Date 2017 Apr 15
PMID 28409739
Citations 28
Authors
Helen Campbell
Michael Edelstein
Nick Andrews
Ray Borrow
Mary Ramsay
Shamez Ladhani
Affiliations
Soon will be listed here.
Abstract

During the first 12 months of an emergency meningococcal ACWY vaccination program for teenagers in England, coverage among persons who left school in 2015, the first cohort to be vaccinated, was 36.6%. There were 69% fewer group W meningococcal cases than predicted by trend analysis and no cases in vaccinated teenagers.

Citing Articles

Epidemiology of Meningococcal Disease in Four South American Countries and Rationale of Vaccination in Adolescents from the Region: Position Paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE).

Villena R, Safadi M, Gentile A, Pujadas M, De la Maza V, George S Vaccines (Basel). 2023; 11(12).

PMID: 38140244 PMC: 10748232. DOI: 10.3390/vaccines11121841.

Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, August 2021-January 2022, England.

Aiano F, Ireland G, Powell A, Campbell C, Judd A, Davies B BMJ Open. 2023; 13(9):e071707.

PMID: 37775287 PMC: 10546110. DOI: 10.1136/bmjopen-2023-071707.

Real-world impact and effectiveness of MenACWY-TT.

Villena R, Kriz P, Htar M, Burman C, Findlow J, Balmer P Hum Vaccin Immunother. 2023; 19(2):2251825.

PMID: 37679903 PMC: 10486281. DOI: 10.1080/21645515.2023.2251825.

Trends in laboratory-confirmed bacterial meningitis (2012-2019): national observational study, England.

Subbarao S, Ribeiro S, Campbell H, Okike I, Ramsay M, Ladhani S Lancet Reg Health Eur. 2023; 32:100692.

PMID: 37538400 PMC: 10393823. DOI: 10.1016/j.lanepe.2023.100692.

Epidemiology, clinical features and outcome of adults with meningococcal meningitis: a 15-year prospective nationwide cohort study.

van Soest T, Chekrouni N, Van Sorge N, Bijlsma M, Brouwer M, van de Beek D Lancet Reg Health Eur. 2023; 30:100640.

PMID: 37181455 PMC: 10173179. DOI: 10.1016/j.lanepe.2023.100640.

References
1.
Ladhani S, Giuliani M, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J . Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England. Emerg Infect Dis. 2016; 22(2):309-11. PMC: 4734511. DOI: 10.3201/eid2202.150369. View
2.
Campbell H, Ladhani S . The importance of surveillance: Group W meningococcal disease outbreak response and control in England. Int Health. 2016; 8(6):369-371. DOI: 10.1093/inthealth/ihw037. View
3.
Tully J, Viner R, Coen P, Stuart J, Zambon M, Peckham C . Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ. 2006; 332(7539):445-50. PMC: 1382533. DOI: 10.1136/bmj.38725.728472.BE. View
4.
Parikh S, Andrews N, Beebeejaun K, Campbell H, Ribeiro S, Ward C . Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2017; 388(10061):2775-2782. DOI: 10.1016/S0140-6736(16)31921-3. View
5.
Campbell H, Saliba V, Borrow R, Ramsay M, Ladhani S . Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Euro Surveill. 2015; 20(28). DOI: 10.2807/1560-7917.es2015.20.28.21188. View